Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:47 AM
Ignite Modification Date:
2025-12-25 @ 2:47 AM
NCT ID:
NCT03314233
Eligibility Criteria:
Inclusion Criteria:
1. Antenatal diagnosis of CDH, with care in the Center for Fetal Treatment
2. Gestational age ≥ 36 weeks at birth
Exclusion Criteria:
1. Multiple gestation
2. Major anomalies or aneuploidy
3. Enrolled in fetal endoluminal tracheal occlusion (FETO) trial
4. Palliative care planned or considered
5. Maternal diagnosis placenta previa, accreta, or abruption
6. Maternal diagnosis pre-eclampsia requiring Magnesium sulfate therapy at time of delivery
7. Obstetrics (OB) or Neonatal provider concerns for the clinical care of the mother or infant, or study team not available
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
1 Day
Study:
NCT03314233
Study Brief:
Protocol Section:
NCT03314233